Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI).

Autor: Elvidge J; National Institute for Health and Care Excellence (NICE), England, UK. Electronic address: jamie.elvidge@nice.org.uk., Hawksworth C; National Institute for Health and Care Excellence (NICE), England, UK., Avşar TS; National Institute for Health and Care Excellence (NICE), England, UK., Zemplenyi A; Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Pécs, Hungary; University of Colorado Anschutz Medical Campus, Denver, CO, USA; Syreon Research Institute, Budapest, Hungary., Chalkidou A; National Institute for Health and Care Excellence (NICE), England, UK., Petrou S; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, England, UK., Petykó Z; Syreon Research Institute, Budapest, Hungary., Srivastava D; Department of Health Policy, London School of Economics and Political Science, London, England, UK., Chandra G; Biomimetics and Intelligent Systems Group, University of Oulu, Oulu, Finland., Delaye J; EURORDIS, Brussels, Belgium., Denniston A; Institute of Inflammation and Ageing, University of Birmingham, Birmingham, England, UK., Gomes M; Department of Primary Care and Population Health, University College London, England, UK., Knies S; National Healthcare Institute (ZIN), Diemen, The Netherlands., Nousios P; Dental and Pharmaceutical Benefits Agency (TLV), Stockholm, Sweden., Siirtola P; Biomimetics and Intelligent Systems Group, University of Oulu, Oulu, Finland., Wang J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands., Dawoud D; National Institute for Health and Care Excellence (NICE), England, UK.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Sep; Vol. 27 (9), pp. 1196-1205. Date of Electronic Publication: 2024 May 23.

A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.

Autor: Wang J; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Pouwels X; Department of Health Technology and Services Research, Faculty of Behavioural, Management, and Social Sciences, TechMed Centre, University of Twente, Enschede, The Netherlands., Ramaekers B; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, CAPHRI Care and Public Health Research Institute, Maastricht, The Netherlands., Frederix G; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., van Lieshout C; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands., Hoogenveen R; Department of Statistics, Modelling and Data Science, Center of Research and Data services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Li X; University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Groningen, The Netherlands., de Wit GA; Department of Epidemiology and Health Economics, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.; Centre for Public Health, Healthcare and Society, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.; Department of Health Sciences, Faculty of Beta Sciences, Vrije Universiteit Amsterdam & Amsterdam Public Health Institute, Amsterdam, The Netherlands., Joore M; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, CAPHRI Care and Public Health Research Institute, Maastricht, The Netherlands., Koffijberg H; Department of Health Technology and Services Research, Faculty of Behavioural, Management, and Social Sciences, TechMed Centre, University of Twente, Enschede, The Netherlands., van Giessen A; Department of Statistics, Modelling and Data Science, Center of Research and Data services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Knies S; National Health Care Institute, Diemen, The Netherlands., Feenstra T; University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, Groningen, The Netherlands. t.l.feenstra@rug.nl.; Centre for Public Health, Healthcare and Society, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. t.l.feenstra@rug.nl.

Publikováno v: PharmacoEconomics [Pharmacoeconomics] 2024 Jul; Vol. 42 (7), pp. 797-810. Date of Electronic Publication: 2024 Apr 13.

Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan

Autor: Mandrik O, Knies S, Severens JL

Publikováno v: ClinicoEconomics and Outcomes Research, Vol 2015, Iss default, Pp 347-356 (2015)

Olena Mandrik,1 Saskia Knies,1,2 Johan L Severens1,3 1Institute of Health Policy and Management, Erasmus University, Rotterdam, 2National Health Care Institute, Diemen, 3iMTA Institute of Medical Technology Assessment, Erasmus University, Rotterdam,

Externí odkaz: https://doaj.org/article/83bcbdef349849659b565fc143f7e163

Cost-Effectiveness of SGLT2 Inhibitors in a Real-World Population: A MICADO Model-Based Analysis Using Routine Data from a GP Registry.

Autor: Li X; University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. li.xinyu@rug.nl., Hoogenveen R; Expertise Center for Methodology and Information Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., El Alili M; Department of Health Sciences, Faculty of Science, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Zorginstituut Nederland, Diemen, The Netherlands., Knies S; Zorginstituut Nederland, Diemen, The Netherlands.; Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands., Wang J; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Beulens JWJ; Department of Epidemiology and Data Sciences, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands.; Amsterdam Public Health, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Elders PJM; Amsterdam Public Health, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands.; Department of General Practice, Amsterdam University Medical Center, Location Vrije Universiteit, Amsterdam, The Netherlands., Nijpels G; Amsterdam Public Health, Amsterdam Cardiovascular Sciences, Amsterdam, The Netherlands., van Giessen A; Expertise Center for Methodology and Information Services, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Feenstra TL; University of Groningen, Faculty of Science and Engineering, Groningen Research Institute of Pharmacy, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Center for Nutrition, Prevention and Health Services Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Publikováno v: PharmacoEconomics [Pharmacoeconomics] 2023 Oct; Vol. 41 (10), pp. 1249-1262. Date of Electronic Publication: 2023 Jun 10.

Recommendations for patient involvement in health technology assessment in Central and Eastern European countries.

Autor: Jakab I; Syreon Research Institute, Budapest, Hungary.; Patient advocate, Budapest, Hungary., Dimitrova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Houÿez F; European Organisation for Rare Diseases (EURORDIS), Paris, France., Bereczky T; Patvocates GmbH, Riemerling, Germany., Fövényes M; Lymfoma Slovensko, Bratislava, Slovakia., Maravic Z; Digestive Cancers Europe, Brussels, Belgium., Belina I; Coalition of Associations in Healthcare, Zagreb, Croatia., Andriciuc C; Romanian Federation of Diabetes Associations, Cluj Napoca, Romania., Tóth K; Syreon Research Institute, Budapest, Hungary.; Bridge of Health Alliance against Breast Cancer Association, Budapest, Hungary., Piniazhko O; Health Technology Assessment Department of State Expert Centre, Ministry of Health of Ukraine, Kyiv, Ukraine., Hren R; Syreon Research Institute, Budapest, Hungary.; Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia., Gutierrez-Ibarluzea I; Basque Foundation for Health Innovation and Research, Landa, Spain., Czech M; Head of Pharmacoeconomic Department, Institute of Mother and Child, Warsaw, Poland., Tesar T; Department of Organisation and Management in Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia., Niewada M; Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland., Lorenzovici L; Syreon Research Romania, Tirgu Mures, Romania.; Department of Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science, and Technology, Targu Mures, Romania., Kamusheva M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Manova M; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Savova A; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; National Council on Prices and Reimbursement of Medicines, Sofia, Bulgaria., Mitkova Z; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Tachkov K; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria., Németh B; Syreon Research Institute, Budapest, Hungary., Petykó ZI; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary., Dawoud D; Science, Policy and Research Programme, National Institute for Health and Care Excellence, London, United Kingdom., Delnoij D; National Health Care Institute (ZIN), Diemen, Netherlands., Knies S; National Health Care Institute (ZIN), Diemen, Netherlands., Goettsch W; National Health Care Institute (ZIN), Diemen, Netherlands.; WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, Netherlands., Kaló Z; Syreon Research Institute, Budapest, Hungary.; Centre for Health Technology Assessment, Semmelweis University, Budapest, Hungary.

Publikováno v: Frontiers in public health [Front Public Health] 2023 Jul 03; Vol. 11, pp. 1176200. Date of Electronic Publication: 2023 Jul 03 (Print Publication: 2023).